Protein tyrosine phosphatase receptor R and Z1 expression as independent prognostic indicators in oral squamous cell carcinoma

Head and Neck

Volumn 37, Issue 12, 2015, Pages 1816-1822

  Dus̈ Szachniewicz, Kamila ^a   Woźniak, Marta ^a   Nelke, Kamil ^a   Gamian, Elzbieta ^a   Gerber, Hanna ^a   Ziõłkowski, Piotr ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

immunohistochemistry; oral cavity squamous cell carcinoma (SSC); protein tyrosine phosphatase receptor R and Z1; protein tyrosine phosphatases (PTPs); Western blot analysis

Indexed keywords

PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE RECEPTOR R; PROTEIN TYROSINE PHOSPHATASE RECEPTOR TYPE Z POLYPEPTIDE 1; UNCLASSIFIED DRUG; PROTEIN TYROSINE KINASE; PTPRZ1 PROTEIN, HUMAN; RECEPTOR LIKE PROTEIN TYROSINE PHOSPHATASE; TUMOR MARKER;

ADULT; ARTICLE; CANCER GRADING; CANCER PATIENT; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CANCER TISSUE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MOUTH SQUAMOUS CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING; CARCINOMA, SQUAMOUS CELL; ENZYMOLOGY; GENETICS; METABOLISM; MIDDLE AGED; MORTALITY; MOUTH NEOPLASMS; PREDICTIVE VALUE; PROGNOSIS; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS; UNIVERSITY HOSPITAL;

BIOMARKERS, TUMOR; CARCINOMA, SQUAMOUS CELL; HOSPITALS, UNIVERSITY; HUMANS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROTEIN TYROSINE PHOSPHATASES; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTOR-LIKE PROTEIN TYROSINE PHOSPHATASES, CLASS 5; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS;

EID: 84983579920     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.23835     Document Type: Article

References (26)

1. European Cancer Observatory. Available at: http://eco.iarc.fr/Default.aspx. Accessed October 1, 2013.
2. Edwards BK, Brown ML, Wingo PA, et al., Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment. J Natl Cancer Inst 2005; 97: 1407-1427.
3. Barnes L, Eveson JW, Reichart P, Sidransky D,. Pathology and Genetics of Head and Neck Tumours, third edition. World Health Organization Classification of Tumors, volume 9. Lyon, France: IARC Press; 2005.
4. Pasini FS, Maistro S, Snitcovsky I, et al., Four-gene expression model predictive of lymph node metastases in oral squamous cell carcinoma. Acta Oncol 2012; 51: 77-85.
5. van Zyl AW, Marnewick JC,. Aetiology of oral cancer. SADJ 2012; 67: 554-556.
6. Tezal M, Sullivan Nasca M, Stoler DL, et al., Chronic periodontitis-human papillomavirus synergy in base of tongue cancers. Arch Otolaryngol Head Neck Surg 2009; 135: 391-396.
7. Krüger M, Hansen T, Kasaj A, Moergel M,. The correlation between chronic periodontitis and oral cancer. Case Rep Dent 2013; 2013: 262410.
8. Mustelin T, Feng GS, Bottini N, et al., Protein tyrosine phosphatases. Front Biosci 2002; 7: 85-142.
9. Zambuzzi WF, Granjeiro JM, Parikh K, Yuvaraj S, Peppelenbosch MP, Ferreira CV,. Modulation of Src activity by low molecular weight protein tyrosine phosphatase during osteoblast differentiation. Cell Physiol Biochem 2008; 22: 497-506.
10. Blume-Jensen P, Hunter T,. Oncogenic kinase signaling. Nature 2001; 411: 355-365.
11. Foehr ED, Lorente G, Kuo J, Ram R, Nikolich K, Urfer R,. Targeting of the receptor protein tyrosine phosphatase beta with a monoclonal antibody delays tumor growth in a glioblastoma model. Cancer Res 2006; 66: 2271-2278.
12. Kim JS, Shin OR, Kim HK, et al., Overexpression of protein phosphatase non-receptor type 11 (PTPN11) in gastric carcinomas. Dig Dis Sci 2010; 55: 1565-1569.
13. Huang JK, Ferrari CC, Monteiro de Castro G, et al., Accelerated axonal loss following acute CNS demyelination in mice lacking protein tyrosine phosphatase receptor type Z. Am J Pathol 2012; 181: 1518-1523.
14. Alonso A, Sasin J, Bottini N, et al., Protein tyrosine phosphatases in the human genome. Cell 2004; 117: 699-711.
15. Shi C, Zhang K, Xu Q,. Gender-specific role of the protein tyrosine phosphatase receptor type R gene in major depressive disorder. J Affect Disord 2012; 136: 591-598.
16. Laczmanska I, Karpinski P, Bebenek M, et al., Protein tyrosine phosphatase receptor-like genes are frequently hypermethylated in sporadic colorectal cancer. J Hum Genet 2013; 58: 11-15.
17. Menigatti M, Cattaneo E, Sabates-Bellver J, et al., The protein tyrosine phosphatase receptor type R gene is an early and frequent target of silencing in human colorectal tumorigenesis. Mol Cancer 2009; 8: 124.
18. Woźniak M, Gamian E, Łaczmańska I, Sąsiadek MM, Dus̈-Szachniewicz K, Ziõłkowski P,. Immunohistochemical and Western blot analysis of two protein tyrosine phosphatase receptors, R and Z1, in colorectal carcinoma, colon adenoma and normal colon tissues. Histol Histopathol 2014; 29: 635-639.
19. Neel BG, Tonks NK,. Protein tyrosine phosphatases in signal transduction. Curr Opin Cell Biol 1997; 9: 193-204.
20. Yang Y, Gil MC, Choi EY, Park SH, Pyun KH, Ha H,. Molecular cloning and chromosomal localization of a human gene homologous to the murine R-PTP-kappa, a receptor-type protein tyrosine phosphatase. Gene 1997; 186: 77-82.
21. Ostman A, Böhmer FD,. Regulation of receptor tyrosine kinase signaling by protein tyrosine phosphatases. Trends Cell Biol 2001; 11: 258-266.
22. Veeriah S, Brennan C, Meng S, et al., The tyrosine phosphatase PTPRD is a tumor suppressor that is frequently inactivated and mutated in glioblastoma and other human cancers. Proc Natl Acad Sci U S A 2009; 106: 9435-9440.
23. Motiwala T, Kutay H, Ghoshal K, et al., Protein tyrosine phosphatase receptor-type O (PTPRO) exhibits characteristics of a candidate tumor suppressor in human lung cancer. Proc Natl Acad Sci U S A 2004; 101: 13844-13849.
24. Su PH, Lin YW, Huang RL, et al., Epigenetic silencing of PTPRR activates MAPK signaling, promotes metastasis and serves as a biomarker of invasive cervical cancer. Oncogene 2013; 32: 15-26.
25. Thomas B, Stedman M, Davies L,. Grade as a prognostic factor in oral squamous cell carcinoma: a population-based analysis of the data. Laryngoscope 2014; 124: 688-694.
26. Liu CH, Chen HJ, Wang PC, Chen HS, Chang YL,. Patterns of recurrence and second primary tumors in oral squamous cell carcinoma treated with surgery alone. Kaohsiung J Med Sci 2013; 29: 554-559.